Asterand Bioscience Wins $6.5 Million Contract From National Institutes Of Health
DETROIT - Asterand Bioscience says it has been awarded a five-year, $6.5 million contract from the National Institutes of Health to provide oncology specimens with associated clinical data to the Clinical Proteomic Tumor Analysis Consortium. The CPTAC is a coordinated effort to accelerate the understanding of the molecular basis of cancer by systematically identifying proteins